News

AstraZeneca PLC (NASDAQ:AZN) is one of Goldman Sachs’ top healthcare stock picks. On July 4, the company secured regulatory ...
Pfizer’s Nurtec and AstraZeneca’s Breztri topped an analysis of the digital and omnichannel marketing strategies of the top pharma brands released Thursday morning. Trinity Life Sciences published its ...
AstraZeneca has reported positive outcomes from the BaxHTN Phase III trial, indicating that the highly selective aldosterone synthase inhibitor (ASI), baxdrostat, significantly reduced the mean seated ...
AstraZeneca AZN is one of the leading drugmakers in the oncology space. Oncology sales (comprising around 41% of ...
AstraZeneca’s Phase III BaxHTN trial shows that baxdrostat significantly lowers systolic blood pressure in resistant ...
Highwire names 5W, Ketchum alum Michael O’Brien as CEO Jess Ruderman May 15, 2025 ‘Hollywood can impact change’: Ryan Reynolds on raising awareness about Parkinson’s-related hallucinations Lecia ...
AstraZeneca chief executive Pascal Soriot is considering moving the company's stock exchange listing from the UK to the US – ...
US pharma major AstraZeneca today released high-level results from the Cardiac Amyloid Reaching for Extended Survival (CARES) ...
Bangalore: AstraZeneca Pharma India Limited has received permission from the Central Drugs Standard Control Organisation ...
AstraZeneca is scheduled to report results for the first quarter on Tuesday. Here is what you need to know. CORE EARNINGS PER SHARE: Core earnings per share--one of the British pharmaceutical ...